Acute hemorrhagic necrotizing pancreatitis
Acute hemorrhagic necrotizing pancreatitis is a type of acute pancreatitis, which is caused by the continued development of acute edematous pancreatitis. Large areas of pancreatic acinar, fat, and blood vessels are necrotic, pancreatic tissue is edematous, the volume increases, and extensive hemorrhagic necrosis occurs. A large amount of bloody exudate is exuded from the retroperitoneum. The omentum and mesentery tissues are digested by the exuded pancreatic enzymes. This type of pancreatitis is serious and develops rapidly, with many complications and a high mortality rate.
-
Site of disease:
pancreas -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Abdominal pain with shock abdominal tenderness high fever upper abdominal mass bloody exudate -
Concurrent disease:
Related Drugs
Gabexate mesylate
Indication: It is used for the treatment of acute mild (edema type) pancreatitis, and can also be used as an auxiliary treatment for acute hemorrhagic necrotic pancreatitis.
Manufacturer:
Lanxiha Sanlian Pharmaceutical Co., Ltd.
Gabexate mesylate
Indication: It is used for the treatment of acute mild (edema type) pancreatitis, and can also be used as an auxiliary treatment for acute hemorrhagic necrotic pancreatitis.
Gabexate mesylate
Indication: It is used for the treatment of acute mild (edema type) pancreatitis, and can also be used as an auxiliary treatment for acute hemorrhagic necrotic pancreatitis.
Manufacturer:
Changzhou Siyao Pharmaceuticals Co., Ltd.
Gabexate mesylate
Indication: It is used for the treatment of acute mild (edema type) pancreatitis, and can also be used as an auxiliary treatment for acute hemorrhagic necrotic pancreatitis.
Manufacturer:
Shanxi PUDE Pharmaceutical Co., Ltd.
Gabexate Mesylate for Injection
Indication: It is used for the treatment of acute mild (edema type) pancreatitis, and can also be used as an auxiliary treatment for acute hemorrhagic necrotic pancreatitis.
Related Ingredients